Standard semaglutide titration: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Week 13+: 1.7 mg or 2.4 mg weekly (target dose) Hashimoto's-adjusted approach: Weeks 1-6: 0.25 mg weekly (extended to allow thyroid monitoring at week 6) Weeks 7-12: 0.5 mg weekly (TSH check before increasing) Weeks 13-16: 1.0 mg weekly Week 17+: Assess whether higher doses are needed The extended timeline allows for thyroid function checks at each step, ensuring levothyroxine doses are adjusted proactively rather than reactively
Biochemical and molecular characterization of the mitochondrial peroxiredoxin PsPrxII F from Pisum sativum
Common warning signs include metabolic changes, unexplained weight gain, cognitive difficulties, mood changes, sleep disturbances, neck swelling, and, in some cases, vision problems
After opening, store in the fridge to prevent oxidation
They want people to be proud of themselves
Though Retatrutides availability is pending, Klinic provides options already endorsed by the FDA